James Briscoe group project:

Development of the serotonergic system

Located in the brainstem, serotonergic neurons are a clinically important neuronal subtype that are generated in response to high levels of Shh signalling. Serotonergic neurons innervate virtually the entire CNS and regulate numerous physiological and behavioural processes, including mood, appetite, locomotion and cognition. Consequently, abnormal serotonergic function is implicated in several common neurological and psychiatric diseases including autism, depression, movement and headache disorders. Knowledge of the molecular programmes that control the differentiation of serotonergic neurons would provide greater understanding of the pathophysiological mechanisms associated with these conditions. To this end, John Jacob, a clinical fellow in the lab is elucidating the genetic networks that regulate the specification and differentiation of this cell type.

Serotonergic neurons are sequentially generated from a bipotent progenitor pool that first generates visceral motor neurons. Sequential cross-repression between two transcription factors, Foxa2 and Phox2b expressed in the common progenitor triggers the temporal identity switch, and instructs the serotonergic differentiation program. We are now beginning to piece together the pathways that link progenitor specification with the acquisition of serotonergic traits, in particular neurotransmitter identity. Currently, we are investigating how the spatial distribution of serotonergic neurons is regulated, with a view to understanding the molecular mechanism of serotonergic dysgenesis in certain autism spectrum disorders.

The serotonergic system in the brainstem

The serotonergic system in the brainstem

Click image to view at full-size

Selected publications

Top of page

© MRC National Institute for Medical Research
The Ridgeway, Mill Hill, London NW7 1AA